Announcement under Regulation 30 (LODR)-Investor Presentation
Filed with BSE · · 43 pages · English
Summary by 6ix AI
Sudarshan Pharma Industries Ltd has submitted an updated Investor Presentation as required by regulatory obligations. The presentation outlines the company's background, product offerings, and global reach in the specialty chemicals and pharmaceutical sectors. It highlights recent milestones, including the establishment of a new manufacturing unit and certifications for quality standards. The document also discusses the company's strategic goals for expanding its market presence and product range in the coming years.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Aug 17 2026
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- Sudarshan Pharma Industries Ltd Press Release Aug 14 2026
- FCCB Committee Meeting On Wednesday, 19-August-2026
- Sudarshan Pharma Industries Ltd Press Release Aug 10 2026
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sudarshan Pharma Industries Ltd Press Release Aug 18 2026
- Sudarshan Pharma Industries Ltd Press Release Aug 22 2026
- Annual General Meeting Of The Company On Tuesday, 22/September/2026
- Reg. 34 (1) Annual Report.
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries